Search

Your search keyword '"Fuzeon (Medication) -- Product introduction"' showing total 7 results
Start Over Descriptor "Fuzeon (Medication) -- Product introduction"
7 results on '"Fuzeon (Medication) -- Product introduction"'

1. Roche and Trimeris gain approval for H.I.V. drug

Subjects
Trimeris Inc. -- Product introduction, Roche Holding AG -- Product introduction, Fuzeon (Medication) -- Product introduction, HIV (Viruses) -- Drug therapy, Biotechnology industry -- Product introduction, Pharmaceutical industry -- Product introduction
Abstract

Roche Holding and Trimeris Inc. won approval in the United States to sell Fuzeon, the first of a new group of H.I.V. medicines that may extend the lives of patients […]

Published
2003

3. HIV drug approved

Subjects
Hoffmann-La Roche Inc. -- Product introduction, Fuzeon (Medication) -- Product introduction, Pharmaceutical industry -- Product introduction, Anti-HIV agents -- Product introduction, Antiviral agents -- Product introduction
Abstract

Fuzeon (enfuvirtide) is approved for injection, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in treatment-experienced patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy. [...]

Published
2004

4. Roche/Trimeris's Fuzeon launched in the UK

Subjects
Trimeris Inc. -- Product introduction, Roche Holding AG -- Product introduction, HIV (Viruses) -- Care and treatment, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Fuzeon (Medication) -- Product introduction
Abstract

Trimeris' and Roche's Fuzeon HIV drug has been introduced in the United Kingdom. The United Kingdom is the HIV-1 drug's second market in the European Union.

Published
2003

5. New class of HIV treatment. (Products)

Subjects
Roche Holding AG -- Product introduction, Fuzeon (Medication) -- Product introduction, Pharmaceutical industry -- Product information, HIV infection -- Drug therapy, Anti-HIV agents -- Innovations, Antiviral agents -- Innovations
Abstract

Fuzeon (enfuvirtide) is approved for use in combination with other anti-HIV medications to treat advanced HIV-1 infection in adults and children aged 6 years and older. The product is the [...]

Published
2003

6. First fusion inhibitor will be in great demand and short supply. (Regulatory Actions)

Subjects
Roche Holding AG -- Product introduction, Trimeris Inc. -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Fuzeon (Medication) -- Product introduction
Abstract

Fuzeon will be reviewed as a priority drug and could be approved by March 2003. In October 2002, the U.S. Food and Drug Administration granted priority-review status to Fuzeon, the [...]

Published
2003

7. Swiss, U.S. firms say they have submitted application for new AIDS drug

Subjects
Trimeris Inc. -- Product introduction, Roche Holding AG -- Product introduction, Fuzeon (Medication) -- Product introduction, Pharmaceutical industry -- Product introduction, Anti-HIV agents -- Product introduction, Antiviral agents
Abstract

2002 OCT 14 - (NewsRx.com & NewsRx.net) -- Swiss pharmaceutical giant Roche and its U.S. partner, North Carolina-based Trimeris, Inc., said September 17, 2002, that they had applied to the [...]

Published
2002

Catalog

Books, media, physical & digital resources
See catalog results